Cambridge Open Engage home
What is Cambridge Open Engage?
How to Submit
Browse
About
News [opens in a new tab]

Possible Drug Candidates for COVID-19

17 March 2020, Version 1
Working Paper
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

COVID-19, has been officially labeled as a pandemic by the World Health Organisation. This paper presents cloperastine and vigabatrin as two possible drug candidates for combatting the disease along with the process by which they were discovered. The paper presents the discoveries made by using a connectivity map and the docking configurations used to simulate the docking.

Keywords

COVID-19

Supplementary materials

Title
Description
Actions
Title
6LU7
Description
Actions
Title
6Y84
Description
Actions
Title
COVID 19
Description
Actions
Title
GEO+Signatures+of+Differentially+Expressed+Genes+for+Viral+Infections
Description
Actions
Title
HCoV EMC2012 24Hour 23631916 GSE45042
Description
Actions
Title
icSARS Cov Day7 None GSE50000
Description
Actions
Title
README
Description
Actions
Title
paper
Description
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.

Version History

Mar 17, 2020 Version 1

Version Notes

1.0 Added experiment results 1.0.1 Added abstract to paper

Metrics

7,825
4,300
3
Views
Downloads

License

CC logo
CC
BY logo
BY
The content is available under CC BY 4.0 [opens in a new tab]

DOI

10.26434/chemrxiv.11985231.v1
D O I: 10.26434/chemrxiv.11985231.v1 [opens in a new tab]

Author’s competing interest statement

no conflict of interest

Share